Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke
- PMID: 21099215
- PMCID: PMC3202928
- DOI: 10.1159/000321791
Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke
Abstract
A 12-year-old boy with HbSS sickle cell disease (SCD) was admitted with an acute febrile illness and developed overt stroke 3 days later. Plasma glial fibrillary acidic protein levels were elevated, as compared to pediatric controls, 32 h prior to the clinical diagnosis of stroke, peaked immediately prior to the exchange transfusion, and remained elevated 1 year later despite chronic transfusion therapy. Stroke in SCD can occur in the setting of acute illness, and a biomarker that could predict the onset and triage ill children to therapeutic intervention more quickly would be useful.
Copyright © 2010 S. Karger AG, Basel.
Figures
References
-
- Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294. - PubMed
-
- Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114:5117–5125. - PubMed
-
- Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–2778. - PubMed
-
- Woertgen C, Rothoerl RD, Wiesmann M, Missler U, Brawanski A. Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl. 2002;81:205–207. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
